Daclizumab Subcutaneous and Loteprednol Eye Drops 0.2%
Determining the interaction of Daclizumab Subcutaneous and Loteprednol Eye Drops 0.2% and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Loteprednol (ophthalmic), Loteprednol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Daclizumab Subcutaneous-Loteprednol Eye Gel
- Daclizumab Subcutaneous-Loteprednol Eye Ointment
- Daclizumab Subcutaneous-Loteprednol ophthalmic
- Daclizumab Subcutaneous-Lotrel
- Daclizumab Subcutaneous-Lotriderm Topical
- Loteprednol Eye Drops 0.2%-Dacogen
- Loteprednol Eye Drops 0.2%-Dacomitinib
- Loteprednol Eye Drops 0.2%-Dactinomycin
- Loteprednol Eye Drops 0.2%-Dactinomycin Injection
- Loteprednol Eye Drops 0.2%-Dactinomycin Intravenous
- Loteprednol Eye Drops 0.2%-Daklinza